Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

This extended–release capsule contains a combination of morphine, a mu–opioid receptor agonist, and naltrexone, a mu–opioid receptor antagonist. This combination was approved on August 13, 2009, for the management of moderate–to–severe pain when a continuous, around–the–clock opioid analgesic is needed for an extended period of time.

Today in Drug Approvals...keeping you current

Boston Scientific Announces FDA Clearance and CE Mark for WallFlex Fully Covered Esophageal Stent
Boston Scientific, 11/24/09

Dendreon Receives FDA Acknowledgement of Complete Response
Dendreon Coproration, 11/23/09

ImmunoGen, Inc. Announces Second License Taken by Amgen for Right to Use the Companys TAP Technology
ImmunoGen, Inc., 11/20/09

Today in Pain Management...keeping you current

Pregabalin, celecoxib, and their combination for treatment of chronic low-back pain
Journal of Orthopaedics and Traumatology, 11/24/09

Postoperative analgesic effect of preoperative intravenous flurbiprofen in arthroscopic rotator cuff repair
Journal of Anesthesia, 11/24/09

Postoperative analgesia with minidose intrathecal morphine for bipolar hip prosthesis in extremely elderly patients
Journal of Anesthesia, 11/24/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address